Search Results

There are 12926 results for: content related to: Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study

  1. You have free access to this content
    Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 11, November 1999, Pages: 1413–1417, Frieri, Pimpo, Palumbo, Onori, Viscido, Latella, Galletti, Pantaleoni and Caprilli

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00642.x

  2. You have free access to this content
    Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis – a pooled analysis

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 9, November 2011, Pages: 1115–1122, L. Leifeld, R. Pfützer, J. Morgenstern, P. R. Gibson, Y. Marakhouski, R. Greinwald, R. Mueller and W. Kruis

    Version of Record online : 19 SEP 2011, DOI: 10.1111/j.1365-2036.2011.04840.x

  3. Is Once-Daily Mesalazine Equivalent to the Currently Used Twice-Daily Regimen? A Study Performed in 30 Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 47, Issue 3, March 2007, Pages: 334–342, Dr Peggy Gandia, Dr Isabelle Idier and Dr Georges Houin

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006296522

  4. You have free access to this content
    Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis – additional results from two controlled studies

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 7, October 2011, Pages: 747–756, W. J. Sandborn, S. Hanauer, G. R. Lichtenstein, M. Safdi, M. Edeline and M. Scott Harris

    Version of Record online : 16 AUG 2011, DOI: 10.1111/j.1365-2036.2011.04800.x

  5. You have free access to this content
    Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study

    Alimentary Pharmacology & Therapeutics

    Volume 15, Issue 2, February 2001, Pages: 251–256, M. Vecchi, G. Meucci, P. Gionchetti, M. Beltrami, P. Di Maurizio, L. Beretta, E. Ganio, P. Usai, M. Campieri, G. Fornaciari and R. De Franchis

    Version of Record online : 7 JUL 2008, DOI: 10.1046/j.1365-2036.2001.00913.x

  6. You have free access to this content
    MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 11, June 2008, Pages: 1094–1102, G. R. LICHTENSTEIN, M. A. KAMM, W. J. SANDBORN, A. LYNE and R. E. JOSEPH

    Version of Record online : 22 MAR 2008, DOI: 10.1111/j.1365-2036.2008.03688.x

  7. You have free access to this content
    Systematic review: the use of mesalazine in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 23, Issue 7, April 2006, Pages: 841–855, R. BERGMAN and M. PARKES

    Version of Record online : 17 MAR 2006, DOI: 10.1111/j.1365-2036.2006.02846.x

  8. You have free access to this content
    Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 5, September 2015, Pages: 549–558, T. Yamamoto, T. Shimoyama and K. Matsumoto

    Version of Record online : 3 JUL 2015, DOI: 10.1111/apt.13308

  9. Pharmacokinetics of mesalazine pellets in children with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 10, Issue 5, September 2004, Pages: 626–631, Heleen Wiersma, Johanna C. Escher, Karin Dilger, Dietmar Trenk, Marc A. Benninga, Chris J. van Boxtel and Jan Taminiau

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200409000-00019

  10. You have free access to this content
    A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 3, March 1999, Pages: 381–388, GIONCHETTI, ARDIZZONE, BENVENUTI, BIANCHI PORRO, BIASCO, CESARI, D'ALBASIO, DE FRANCHIS, MONTELEONE, PALLONE, RANZI, TRALLORI, VALPIANI, VECCHI and CAMPIERI

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00482.x

  11. You have free access to this content
    Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation – a placebo-controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 3, August 2013, Pages: 264–273, M. Watanabe, H. Nishino, Y. Sameshima, A. Ota, S. Nakamura and T. Hibi

    Version of Record online : 5 JUN 2013, DOI: 10.1111/apt.12362

  12. Development and validation of an LC-MS/MS method for the determination of mesalazine in beagle dog plasma and its application to a pharmacokinetic study

    Biomedical Chromatography

    Volume 29, Issue 2, February 2015, Pages: 261–267, Juan Qin, Xin Di, Xin Wang and Youping Liu

    Version of Record online : 13 JUN 2014, DOI: 10.1002/bmc.3270

  13. You have free access to this content
    The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 11-12, December 2008, Pages: 1287–1296, A. BUCKLAND and K. BODGER

    Version of Record online : 19 SEP 2008, DOI: 10.1111/j.1365-2036.2008.03856.x

  14. You have free access to this content
    Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 12, June 2007, Pages: 1389–1399, A. H. STEINHART, A. FORBES, E. C. MILLS, B. S. RODGERS-GRAY and S. P. L. TRAVIS

    Version of Record online : 30 MAR 2007, DOI: 10.1111/j.1365-2036.2007.03324.x

  15. You have free access to this content
    Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 8, April 2013, Pages: 767–775, B. Flourié, H. Hagège, G. Tucat, D. Maetz, X. Hébuterne, J. P. Kuyvenhoven, T. G. Tan, M. J. Pierik, A. A. M. Masclee, O. Dewit, C. S. Probert, D. Aoucheta and the MOTUS study investigators

    Version of Record online : 4 MAR 2013, DOI: 10.1111/apt.12266

  16. You have free access to this content
    Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 9, September 2000, Pages: 1191–1198, Pokrotnieks, Marlicz, Paradowski, Margus, Zaborowski and Greinwald

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00784.x

  17. Oral mesalazine (5-ASA) treatment may protect against proximal extension of mucosal inflammation in ulcerative proctitis

    Inflammatory Bowel Diseases

    Volume 10, Issue 6, November 2004, Pages: 731–736, Roberta Pica, Omero Alessandro Paoluzi, Federico Iacopini, Adriana Marcheggiano, Pietro Crispino, Margherita Rivera, Antonino Bella, Adriana Consolazio and Prof. Paolo Paoluzi

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200411000-00006

  18. You have free access to this content
    Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 23, Issue 7, April 2006, Pages: 1017–1026, P. R. GIBSON, B. FIXA, B. PEKÁRKOVÁ, M. BÁTOVSKÝ, G. RADFORD-SMITH, J. TIBITANZL, L. GABALEC, T. H. J. FLORIN and R. GREINWALD

    Version of Record online : 17 MAR 2006, DOI: 10.1111/j.1365-2036.2006.02861.x

  19. You have full text access to this OnlineOpen article
    Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence

    Alimentary Pharmacology & Therapeutics

    W. Kruis, V. Kardalinos, T. Eisenbach, M. Lukas, T. Vich, I. Bunganic, J. Pokrotnieks, J. Derova, J. Kondrackiene, R. Safadi, D. Tuculanu, Z. Tulassay, J. Banai, A. Curtin, A. E. Dorofeyev, S. F. Zakko, N. Ferreira, S. Björck, M. M. Diez Alonso, J. Mäkelä, N. J. Talley, K. Dilger, R. Greinwald, R. Mohrbacher and R. Spiller

    Version of Record online : 23 MAY 2017, DOI: 10.1111/apt.14152

  20. Successful treatment with topical mesalazine for a patient with intractable crohn’s colitis

    Digestive Endoscopy

    Volume 14, Issue 1, January 2002, Pages: 16–19, MIZUKI KONO, NOBUHIDE OSHITANI, YOSHINORI SAWA, KAZUHIDE HIGUCHI, TAKAYUKI MATSUMOTO and TETSUO ARAKAWA

    Version of Record online : 24 MAY 2002, DOI: 10.1046/j.1443-1661.2002.00157.x